You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 115 No. 2, February 1997 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  MECHANISMS IN OPHTHALMIC DISEASE
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (106)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Pathogenic Mechanisms in Proliferative Vitreoretinopathy

Peter A. Campochiaro, MD

Arch Ophthalmol. 1997;115(2):237-241.


Abstract



Landmarks in the development of treatment of retinal detachment include the recognition of the significance of retinal breaks that resulted in the distinction between rhegmatogenous retinal detachment (RRD) and exudative retinal detachment, the development of indirect ophthalmoscopy and scleral depression that allow better visualization of the peripheral area of the retina and better identification of retinal breaks, the recognition of the need to seal all retinal breaks, and the realization that vitreous traction is the major underlying cause of retinal tears and RRD. Scleral buckling procedures combine retinopexy to provide a scar around retinal breaks to seal them and scleral indentation to neutralize vitreous traction; they provided the first effective treatment of RRD. As surgeons gained experience with scleral buckling, they became aware that some RRDs, particularly those with fixed folds and/or a funnel configuration, often could not be repaired using this approach. It was thought that excessive vitreous traction was at fault, and the condition was called "massive vitreous retraction."1



Author Affiliations



From the Wilmer Eye Institute and the Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Md.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Expression of PDGFR{alpha} Is a Determinant of the PVR Potential of ARPE19 Cells
Lei et al.
IOVS 2011;52:5016-5021.
ABSTRACT | FULL TEXT  

Tumor Necrosis Factor-{alpha} Regulates Transforming Growth Factor-{beta}-dependent Epithelial-Mesenchymal Transition by Promoting Hyaluronan-CD44-Moesin Interaction
Takahashi et al.
J. Biol. Chem. 2010;285:4060-4073.
ABSTRACT | FULL TEXT  

Integrin {alpha}5{beta}1 Mediates Attachment, Migration, and Proliferation in Human Retinal Pigment Epithelium: Relevance for Proliferative Retinal Disease
Li et al.
IOVS 2009;50:5988-5996.
ABSTRACT | FULL TEXT  

Growth Factors Outside the PDGF Family Drive Experimental PVR
Lei et al.
IOVS 2009;50:3394-3403.
ABSTRACT | FULL TEXT  

Growth Factors Outside of the Platelet-derived Growth Factor (PDGF) Family Employ Reactive Oxygen Species/Src Family Kinases to Activate PDGF Receptor {alpha} and Thereby Promote Proliferation and Survival of Cells
Lei and Kazlauskas
J. Biol. Chem. 2009;284:6329-6336.
ABSTRACT | FULL TEXT  

Expression of CXCL8, CXCR1, and CXCR2 in Neurons and Glial Cells of the Human and Rabbit Retina
Goczalik et al.
IOVS 2008;49:4578-4589.
ABSTRACT | FULL TEXT  

Potent Inhibition of Cicatricial Contraction in Proliferative Vitreoretinal Diseases by Statins
Kawahara et al.
Diabetes 2008;57:2784-2793.
ABSTRACT | FULL TEXT  

Plasmin Is the Major Protease Responsible for Processing PDGF-C in the Vitreous of Patients with Proliferative Vitreoretinopathy
Lei et al.
IOVS 2008;49:42-48.
ABSTRACT | FULL TEXT  

PDGF-C and -D Induced Proliferation/Migration of Human RPE Is Abolished by Inflammatory Cytokines
Li et al.
IOVS 2007;48:5722-5732.
ABSTRACT | FULL TEXT  

Cross Talk between c-Met and Epidermal Growth Factor Receptor during Retinal Pigment Epithelial Wound Healing
Xu and Yu
IOVS 2007;48:2242-2248.
ABSTRACT | FULL TEXT  

A Potential Role for PDGF-C in Experimental and Clinical Proliferative Vitreoretinopathy
Lei et al.
IOVS 2007;48:2335-2342.
ABSTRACT | FULL TEXT  

Functional Characteristics of Connective Tissue Growth Factor on Vitreoretinal Cells
Kita et al.
Diabetes 2007;56:1421-1428.
ABSTRACT | FULL TEXT  

N-Cadherin Expression in a Rat Model of Retinal Detachment and Reattachment
Chen and Ma
IOVS 2007;48:1832-1838.
ABSTRACT | FULL TEXT  

Vitreous Modulation of Gene Expression in Low-Passage Human Retinal Pigment Epithelial Cells
Ganti et al.
IOVS 2007;48:1853-1863.
ABSTRACT | FULL TEXT  

Transforming Growth Factor-{beta}2 and Connective Tissue Growth Factor in Proliferative Vitreoretinal Diseases: Possible Involvement of Hyalocytes and Therapeutic Potential of Rho Kinase Inhibitor
Kita et al.
Diabetes 2007;56:231-238.
ABSTRACT | FULL TEXT  

p38 MAPK Mediates the Expression of Type I Collagen Induced by TGF-{beta}2 in Human Retinal Pigment Epithelial Cells ARPE-19
Kimoto et al.
IOVS 2004;45:2431-2437.
ABSTRACT | FULL TEXT  

Differential Involvement of Phosphoinositide 3-Kinase/Akt in Human RPE MCP-1 and IL-8 Expression
Bian et al.
IOVS 2004;45:1887-1896.
ABSTRACT | FULL TEXT  

Expression of LRP1 in Retinal Pigment Epithelial Cells and Its Regulation by Growth Factors
Hollborn et al.
IOVS 2004;45:2033-2038.
ABSTRACT | FULL TEXT  

Comparative Proteome Analysis of Native Differentiated and Cultured Dedifferentiated Human RPE Cells
Alge et al.
IOVS 2003;44:3629-3641.
ABSTRACT | FULL TEXT  

The Kinase Inhibitor PKC412 Suppresses Epiretinal Membrane Formation and Retinal Detachment in Mice with Proliferative Retinopathies
Saishin et al.
IOVS 2003;44:3656-3662.
ABSTRACT | FULL TEXT  

Vitreous Induces Components of the Prostaglandin E2 Pathway in Human Retinal Pigment Epithelial Cells
Parapuram et al.
IOVS 2003;44:1767-1774.
ABSTRACT | FULL TEXT  

Vitreous Treatment of Cultured Human RPE Cells Results in Differential Expression of 10 New Genes
Kociok et al.
IOVS 2002;43:2474-2480.
ABSTRACT | FULL TEXT  

Retina-Specific Expression of PDGF-B Versus PDGF-A: Vascular Versus Nonvascular Proliferative Retinopathy
Mori et al.
IOVS 2002;43:2001-2006.
ABSTRACT | FULL TEXT  

PI3K and PLC{gamma} Play a Central Role in Experimental PVR
Ikuno et al.
IOVS 2002;43:483-489.
ABSTRACT | FULL TEXT  

Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy
El-Ghrably et al.
Br J Ophthalmol 2001;85:461-470.
ABSTRACT | FULL TEXT  

Promotion of Adhesion and Migration of RPE Cells to Provisional Extracellular Matrices by TNF-{alpha}
Jin et al.
IOVS 2000;41:4324-4332.
ABSTRACT | FULL TEXT  

EIU in the Rat Promotes the Potential of Syngeneic Retinal Cells Injected into the Vitreous Cavity to Induce PVR
Behar-Cohen et al.
IOVS 2000;41:3915-3924.
ABSTRACT | FULL TEXT  

Elevation of Vitreous Leptin in Diabetic Retinopathy and Retinal Detachment
Gariano et al.
IOVS 2000;41:3576-3581.
ABSTRACT | FULL TEXT  

Src Family Kinases Negatively Regulate Platelet-derived Growth Factor alpha Receptor-dependent Signaling and Disease Progression
Rosenkranz et al.
J. Biol. Chem. 2000;275:9620-9627.
ABSTRACT | FULL TEXT  

Bone Morphogenetic Proteins-2 and -4: Negative Growth Regulators in Adult Retinal Pigmented Epithelium
Mathura et al.
IOVS 2000;41:592-600.
ABSTRACT | FULL TEXT  

Platelet-Derived Growth Factor Plays a Key Role in Proliferative Vitreoretinopathy
Andrews et al.
IOVS 1999;40:2683-2689.
ABSTRACT | FULL TEXT  

Growth factors in proliferative vitreoretinopathy
CHARTERIS
Br J Ophthalmol 1998;82:106-106.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.